Antonio Richetta
7PUBLICATIONS
68CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.Emanuele Trovato, Claudio Bonifati, Simone Ribero
|Jun 27, 2025
Effectiveness of Bimekizumab in Psoriatic Arthritis: A Multicenter Real-Life Study With Clinical and Ultrasound Evaluation in the Lazio Region, Italy.Giacomo Caldarola, Annunziata Dattola, Nicoletta Bernardini
|Feb 27, 2024
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study).Diego Orsini, Giacomo Caldarola, Annunziata Dattola
|Jun 16, 2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year.Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini
|Nov 26, 2021
Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy.Giuseppe Argenziano, Paolo Amerio, Maria Grazia Aragone
|Jul 19, 2021
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy.Arianna Zangrilli, Giacomo Caldarola, Nicoletta Bernardini
Pageof 2
Frequent Collaborators
4 joint publications
Claudio Bonifati
3 joint publications
Giacomo Caldarola
3 joint publications
Gaia Moretta
3 joint publications
Ketty Peris
3 joint publications
Marco Galluzzo
3 joint publications
Gianluca Pagnanelli
2 joint publications
Diego Orsini
2 joint publications
Annunziata Dattola
2 joint publications
Elena Campione
2 joint publications
Maria Concetta Fargnoli
